All eyes are on Pfizer as Trump pushes for vaccine by October

By repeating a date that flies in the face of most scientific predictions, Pfizer's CEO is making a high-stakes gamble. But there is a significant upside, to the tune of billions of dollars, in being first to the market with a vaccine.